Clinical Trials Logo
  1. Home
  2. Head and Neck Cancers
  3. NCT00580203
  4. Details
NCT00580203 Clinical Trial

Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

Head and Neck Cancers Clinical Trial

Official title:
Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT00580203
Other study ID # 04-017
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date February 2004
Est. completion date December 2024

Study information
Verified date December 2023
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.

Description:

This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 1307
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients with head and neck diseases are eligible if they have had tissue, serum, urine, or other specimens removed or collected for diagnostic or therapeutic purposes. - Patients will be entered onto this protocol without preference for any racial or ethnic group. - Patients may have received prior chemotherapy, radiation, surgical therapy, immunotherapy, or differentiation therapy. - The specimen collected must be large enough to allow conventional testing necessary for patient care, with the portion of the specimen reserved for research laboratory analysis excised from residual tissue that would otherwise have been discarded. Exclusion Criteria: - Patients not giving informed consent will be excluded.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Memorial Sloan Kettering Cancer Center New York New York

Sponsors (2)
Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center American Cancer Society, Inc.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Specimens will be used to investigate growth, development, and transformation of normal and abnormal cells in the future. 36 months
See also
  Status Clinical Trial Phase
Terminated NCT00721539 - Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract N/A
Recruiting NCT00568490 - Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Completed NCT01135849 - B-Receptor Signaling in Cardiomyopathy N/A
Completed NCT00313027 - Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation N/A
Completed NCT00186433 - A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations N/A
Recruiting NCT02997332 - Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 1
Completed NCT02854358 - Efficacy of Traditional Persian Medicine Preparation Versus Artificial Saliva for Radiation Induced Xerostomia Phase 2
Terminated NCT01114256 - FNA Tumor Sampling for CD137 Modulation: A Pilot Study N/A
Terminated NCT00965003 - MRI Laryngeal Imaging With a Surface Coil Early Phase 1
Active, not recruiting NCT00490061 - Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy Phase 2
Recruiting NCT05122221 - CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers Phase 1
Completed NCT02045368 - Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R Phase 1
Completed NCT01908504 - Adaptive Pet Study N/A
Completed NCT05648682 - Comparison of the Effectiveness of Three Different Gargates in Radiotherapy-Associated Oral Mucositis N/A
Not yet recruiting NCT03394417 - StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients N/A
Completed NCT00230295 - Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast N/A
Completed NCT00610415 - Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study N/A
Completed NCT01664936 - Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
Completed NCT01163487 - Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers Phase 1
Terminated NCT01137162 - Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors N/A

External Links